16th Policy Dialogue on Universal Healthcare and Access to Medicines
Magandang araw!

2 linggo na lang bago ang 16th Policy Dialogue on Universal Healthcare and Access to Medicines o 16th Patient Forum!

Ito ay gaganapin ng June 9, 2022, 8am-12nn sa Cocoon Boutique Hotel sa Quezon City kung saan tampok ang representatives ng Department of Health, Philippine Health Insurance Corporation, Department of Social Welfare and Development at Philippine Charity Sweepstakes Office para maghatid ng mga impormasyong kaugnay ng serbisyong hatid ng Malasakit Centers.

Ang event ay bukas sa mga patient groups at civil society organizations na gustong dumalo at matuto.

Maraming Salamat.
1st Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Devices List (PEMDL)
ASEAN Member States Virtually Assemble in the recent Drug Price Transparency Workshop
DOH’s 15th Patient Forum Highlights COVID Response, Accessibility of Health Commodities
DOH Announces Full Implementation of Drug Price Caps with Executive Order No. 155
Standard Information, Education and Communication (IEC) Materials for the Implementation of Maximum Drug Retail Price through Executive Order No. 155 s. 2021

A successful initial collaboration of the DOH Pharamceutical Division – Medical Device Unit spearheaded by Dir. Anna Melissa S. Guerrero, MD, MPH (HTA) and Dr. Constante Caluya III, MBA and their Expert Advisory Committee for medical devices and supplies led by Dr. Ronaldo H. Estacio, together with the Health Technology Assessment Division headed by Ms. Anne Julienne Genuino-Marfori, RPh, MSc and their Health Technology Assessment Council chaired by Dr. Marita V. Tolentino-Reyes.

May 20, 2022

The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.

April 20, 2022

The Department of Health (DOH) on March 30, 2022 convened patient groups and civil society organizations (CSOs) to discuss updates on the national government’s COVID-19 response, vaccination program rollout, and the ongoing initiatives to provide Filipinos better access to pharmaceutical commodities and healthcare services during the virtual 15th Policy Dialogue on Universal Health Care (UHC) and Access to Medicines with  theme “Gamot Para sa Lahat, Siguruhing Sasapat”.

April 11, 2022

The Department of Health (DOH) announces the full implementation of drug price caps starting March 23, 2022 through Executive Order (EO) No. 155 signed by President Rodrigo Duterte. This brings the total number of drugs with maximum drug retail price to 121 molecules or 204 drug formulas, following the first round of price regulation implemented in June 2020 with the signing of EO No. 104 which covered 87 molecules.

April 11, 2022

The Executive Order (EO) No. 155, “Further Improving Access to Healthcare Through the Regulation of Prices in the Retail of Drugs and Medicines,” which was issued by President Rodrigo R. Duterte on 07 December 2021, subjected 34 drug molecules or 71 drug formulas under price regulation through Maximum Wholesale Price (MWP) and Maximum Retail Price (MRP). The implementation shall begin on 23 March 2022.

March 16, 2022



Philippine Standard time

Contact Us:

Telephone Number: 02-8757734 Loc. 253

Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City

Email Address: pharmareceiving@doh.gov.ph